We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CUAN:IDXPT Petrindo Jaya Kreasi Tbk Analysis

Data as of 2026-03-15 - not real-time

IDR 1,195.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

CUAN is trading well below its short‑ and long‑term moving averages (price IDR 1,195 vs SMA‑20 of 1,527, SMA‑50 of 1,747 and SMA‑200 of 1,765) and the RSI sits at 26.7, indicating oversold conditions. The MACD remains bearish and the stock is near its technical support at IDR 1,155, while volatility is exceptionally high at over 100% 30‑day. On the fundamentals side, the company reports rapid revenue growth of 41.5% but is hampered by a thin gross margin (8.9%), high debt‑to‑equity of 201.6%, and negative operating and free cash flow, leading to a lofty PE of 57.5 versus an industry average of 22.2.
Material news includes a buyback program of up to IDR 750 bn and significant insider accumulation (≈IDR 10.86 bn) by the Prajogo Pangestu group, alongside a new 680 MW power plant project valued at IDR 10 tn. These actions aim to stabilize the share price and diversify earnings, yet the underlying balance‑sheet strain and sector headwinds keep the outlook cautious.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • RSI in oversold territory suggesting a near‑term rebound
  • Buyback allocation of up to IDR 750 bn providing price support
  • Proximity to technical support at IDR 1,155

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio and negative cash flow limiting flexibility
  • Ongoing 680 MW power project that may improve earnings diversification
  • Persistent bearish technical trend despite improving sentiment

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth but thin margins in a transitioning thermal‑coal sector
  • Potential upside from strategic projects and continued insider confidence
  • Elevated valuation multiples relative to earnings and industry peers

Key Metrics & Analysis

Financial Health

Revenue Growth41.50%
Profit Margin13.92%
P/E Ratio57.5
ROE33.18%
ROA0.58%
Debt/Equity201.59
P/B Ratio398333.3
Op. Cash FlowIDR-14011000
Free Cash FlowIDR-494075360
Industry P/E22.2

Technical Analysis

TrendBearish
RSI26.7
SupportIDR 1,155.00
ResistanceIDR 1,990.00
MA 20IDR 1,527.50
MA 50IDR 1,746.80
MA 200IDR 1,764.64
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target PriceIDR 3,555.09
Upside/Downside197.50%
GradeOvervalued
TypeGrowth
Dividend Yield0.05%

Risk Assessment

Beta0.61
Volatility101.69%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.